DE602005012132D1 - Neue mittel zur prophylaxe und behandlung von erkrankungen in zusammenhang mit beeinträchtigter neurotransmission - Google Patents

Neue mittel zur prophylaxe und behandlung von erkrankungen in zusammenhang mit beeinträchtigter neurotransmission

Info

Publication number
DE602005012132D1
DE602005012132D1 DE602005012132T DE602005012132T DE602005012132D1 DE 602005012132 D1 DE602005012132 D1 DE 602005012132D1 DE 602005012132 T DE602005012132 T DE 602005012132T DE 602005012132 T DE602005012132 T DE 602005012132T DE 602005012132 D1 DE602005012132 D1 DE 602005012132D1
Authority
DE
Germany
Prior art keywords
group
treatment
neurotransmission
empireed
prophylaxis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005012132T
Other languages
English (en)
Inventor
Saizieu Antoine De
Ann Fowler
Regina Goralczyk
Bernd Mussler
Goede Schueler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
DSM IP Assets BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DSM IP Assets BV filed Critical DSM IP Assets BV
Publication of DE602005012132D1 publication Critical patent/DE602005012132D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37Coumarins, e.g. psoralen
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/385Concentrates of non-alcoholic beverages
    • A23L2/39Dry compositions
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10Cereal-derived products
    • A23L7/117Flakes or other shapes of ready-to-eat type; Semi-finished or partly-finished products therefor
    • A23L7/126Snacks or the like obtained by binding, shaping or compacting together cereal grains or cereal pieces, e.g. cereal bars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE602005012132T 2004-10-22 2005-10-21 Neue mittel zur prophylaxe und behandlung von erkrankungen in zusammenhang mit beeinträchtigter neurotransmission Active DE602005012132D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04025165 2004-10-22
PCT/CH2005/000621 WO2006042441A2 (en) 2004-10-22 2005-10-21 Novel agents for preventing and treating disorders connected to impaired neurotransmission

Publications (1)

Publication Number Publication Date
DE602005012132D1 true DE602005012132D1 (de) 2009-02-12

Family

ID=36154615

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005012132T Active DE602005012132D1 (de) 2004-10-22 2005-10-21 Neue mittel zur prophylaxe und behandlung von erkrankungen in zusammenhang mit beeinträchtigter neurotransmission

Country Status (9)

Country Link
US (1) US8044094B2 (de)
EP (1) EP1802298B1 (de)
JP (2) JP2008517879A (de)
KR (1) KR20070068400A (de)
CN (2) CN101703239A (de)
AT (1) ATE418980T1 (de)
DE (1) DE602005012132D1 (de)
ES (1) ES2320686T3 (de)
WO (1) WO2006042441A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006077972A1 (ja) * 2005-01-21 2006-07-27 Arkray, Inc. メタボリックシンドローム改善剤、ならびにそれを含む医薬、サプリメント、機能性食品および食品添加物
US8329239B2 (en) * 2009-03-03 2012-12-11 Givandan S.A. Off-taste masking
WO2011108499A1 (ja) * 2010-03-03 2011-09-09 株式会社エリナ オーラプテン類縁化合物を有効成分とする骨芽細胞分化促進剤、骨形成促進用医薬組成物及び保健機能食品
CN102267966B (zh) * 2011-08-01 2013-02-27 华中科技大学 取代的苯并吡喃酮类衍生物及其应用
JP5945861B2 (ja) * 2011-09-29 2016-07-05 学校法人松山大学 医薬組成物及びその製造方法
JP2018110572A (ja) * 2017-01-13 2018-07-19 国立大学法人千葉大学 DGKδノックアウトマウス及びこれを用いた方法
CN108478568B (zh) * 2018-02-01 2020-08-28 华中农业大学 一种香豆素类化合物在制备单胺氧化酶抑制剂中的用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE713490A (de) * 1967-04-14 1968-10-10
GB1497161A (en) * 1975-07-19 1978-01-05 Beecham Group Ltd Naphthyl derivatives
JPH04128224A (ja) 1989-11-28 1992-04-28 Sankyo Co Ltd クマリン環を有する脳循環代謝改善薬
JP2004131432A (ja) * 2002-10-11 2004-04-30 Kumamoto Technology & Industry Foundation 悪性腫瘍抑制剤
EP1588705A1 (de) 2004-04-21 2005-10-26 INTE:LIGAND Software-Entwicklungs und Consulting GmbH Verwendung von Cumarinderivaten
WO2006024545A1 (en) * 2004-09-03 2006-03-09 Stichting Voor De Technische Wetenschappen Fused bicyclic natural compounds and their use as inhibitors of parp and parp-mediated inflammatory processes

Also Published As

Publication number Publication date
WO2006042441A2 (en) 2006-04-27
WO2006042441A3 (en) 2006-07-13
US8044094B2 (en) 2011-10-25
JP2008517879A (ja) 2008-05-29
CN101043886A (zh) 2007-09-26
KR20070068400A (ko) 2007-06-29
EP1802298A2 (de) 2007-07-04
ATE418980T1 (de) 2009-01-15
ES2320686T3 (es) 2009-05-27
US20070293563A1 (en) 2007-12-20
CN101703239A (zh) 2010-05-12
JP2013063974A (ja) 2013-04-11
EP1802298B1 (de) 2008-12-31

Similar Documents

Publication Publication Date Title
DE602005012132D1 (de) Neue mittel zur prophylaxe und behandlung von erkrankungen in zusammenhang mit beeinträchtigter neurotransmission
DE60224928D1 (de) Dermatologische und kosmetische zusammensetzungen enthaltend ein furfurylderivat
SG146648A1 (en) Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
UA84048C2 (ru) Производные сульфонамида для лечения заболеваний, способ их получения (варианты), фармацевтическая композиция на их основе
TW200505862A (en) 2-amino-pyridine derivatives useful for the treatment of diseases
MXPA05009304A (es) Derivados de indol utiles para el tratamiento de enfermedades.
MY139690A (en) Sulfonamide derivatives for the treatment of diseases.
ATE452129T1 (de) N-phenyl-2-pyrimidine-amine derivatives
ATE543813T1 (de) Neue benzopyranderivate als kaliumkanalöffner
ATE432278T1 (de) Verbindungen zur behandlung von krankheiten
DK1809288T3 (da) Anvendelse af 1,4-bis-(3-aminoalkyl)piperazinderivater ved behandling af neurodegenerative sygdomme
EA200601510A1 (ru) Производные фенилэтаноламина в качестве бета-2-агонистов
GEP20053590B (en) Phenyl Heterocyclyl Ether Derivatives as Serotonin Re-Uptake Inhibitors
DE59909607D1 (de) Tan-1057 derivate
PL376718A1 (pl) Nowe związki, ich wytwarzanie i stosowanie
HK1117751A1 (en) Dental enamel recalcification accelerator and containing the same, oral composition and food or beverage
TR200402070T4 (tr) Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı
ATE469882T1 (de) Neue verbindungen, die sich f r die behandlung von durch ppar vermittelten krankheiten eignen
ATE464896T1 (de) Zubereitung enthaltend oxidierte flavonoid- derivate
CY1111290T1 (el) Παραγωγα 9-αλκυλαμινo-1-νιτρoακριδινης
ATE471142T1 (de) Aroma- und duftstoffzusammensetzungen
ATE373480T1 (de) Glycosaminoglykane zur behandlung emotionaler störungen
DE602004028113D1 (de) Verwendung von 2,3-Dehydronaringenin-Derivaten zur Behandlung von Entzündungsprozessen und diese Derivate enthaltende pharmazeutische Zusammensetzung
DE60212101D1 (de) Alanin-2,6-dialkoxyphenylesterderivate als hypnotika
DE50212971D1 (de) C2-disubstituierte indan-1-ol-systeme und ihre verwendung als arzneimittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition